Global Medical REIT Inc. GMRE
35.74 USD 0.00 (+0.00%)
Mar 6, 2026, 9:30 AM EST
35.44 Day range 36.14
52-week range unavailable
- YTD
- +5.93%
- 1 year
- -6.68%
Analyst view
Consensus: buy
Buy
Price target (mean) 10.34 -71.1% downside
Now 35.74
- Target (low)
- 9.00
- Target (mean)
- 10.34
- Target (high)
- 12.50
Ratings (0m) 10 5 buy · 5 hold · 0 sell
- Strong buy1
- Buy4
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 9
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.03 | 0.02 – 0.04 | 0.0036 | +733.3% | 35.57M | +3.9% | 2 |
| Next quarter | 0.03 | 0.02 – 0.04 | -0.0005 | +6100.0% | 36.46M | +6.4% | 2 |
| Current year | 0.16 | 0.16 – 0.16 | -0.0254 | +729.9% | 143.28M | +3.3% | 1 |
| Next year | 0.11 | 0.11 – 0.11 | 0.16 | -31.3% | 149.43M | +4.3% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 8, 2025 | Baird | Maintained | Neutral | Neutral |
| Mar 12, 2025 | Citizens Capital Markets | Reiterated | Market Perform | Market Perform |
| Oct 18, 2024 | Berenberg | Initiated | — | Buy |
| Sep 19, 2024 | Alliance Global Partners | Initiated | — | Buy |
| May 13, 2024 | B. Riley Securities | Maintained | Buy | Buy |
| May 8, 2023 | B. Riley Securities | Maintained | — | Buy |
| Mar 6, 2023 | B. Riley Securities | Maintained | — | Buy |
| Oct 10, 2022 | Baird | Downgrade | Outperform | Neutral |
| Oct 6, 2022 | BMO Capital | Downgrade | Outperform | Market Perform |
| Jan 13, 2022 | Keybanc | Downgrade | Overweight | Sector Weight |
| Sep 20, 2021 | Keybanc | Initiated | — | Overweight |
| Jul 9, 2021 | Colliers Securities | Initiated | — | Buy |
| Apr 16, 2021 | BMO Capital | Initiated | — | Outperform |
| Mar 18, 2020 | B. Riley Securities | Upgrade | Neutral | Buy |
| Mar 6, 2020 | Baird | Maintained | — | Outperform |
| Mar 6, 2020 | B. Riley Securities | Downgrade | Buy | Neutral |
| Mar 5, 2020 | Stifel | Maintained | — | Buy |
| Jan 7, 2020 | Janney Montgomery Scott | Upgrade | Neutral | Buy |
| Dec 20, 2019 | B. Riley Securities | Maintained | — | Buy |
| Dec 17, 2019 | Stifel | Maintained | — | Buy |
| Nov 7, 2019 | Stifel | Maintained | — | Buy |
| Apr 15, 2019 | Stifel | Initiated | — | Buy |
| Dec 20, 2018 | Janney Montgomery Scott | Downgrade | Buy | Neutral |
| Nov 7, 2018 | Boenning & Scattergood | Upgrade | Neutral | Outperform |
| Oct 11, 2018 | Baird | Initiated | — | Outperform |
| May 10, 2018 | B. Riley Securities | Maintained | Buy | Buy |
| Mar 29, 2018 | DA Davidson | Upgrade | Neutral | Buy |
| Sep 18, 2017 | FBR Capital | Maintained | — | Buy |
| Sep 1, 2017 | Cantor Fitzgerald | Initiated | — | Overweight |
| Aug 22, 2017 | DA Davidson | Downgrade | Buy | Neutral |